Codes / ICD10CM / L94.1

L94.1 Linear scleroderma

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Linear scleroderma

Summary

Linear scleroderma is a localized form of scleroderma characterized by thickening and hardening of the skin in linear bands or streaks, typically affecting the limbs, face, or trunk. It results from excessive collagen production in the skin and underlying tissues, leading to skin tightening, discoloration, and potential functional impairment. The condition progresses slowly and may involve underlying structures such as muscles or bones.

Causes

The exact cause of linear scleroderma is not fully understood, but it is believed to involve an abnormal immune response that triggers excessive collagen production. Genetic factors may play a role, as the condition sometimes clusters in families. Environmental triggers, such as infections or trauma, have been suggested but remain unproven.

Risk Factors

  • Age: Most commonly diagnosed in children and young adults.
  • Gender: Slightly more prevalent in females.
  • Family history: A genetic predisposition may increase risk.
  • Autoimmune conditions: Individuals with other autoimmune disorders may have a higher likelihood.

Symptoms

  • Linear bands of hardened, discolored skin, often on the limbs or face.
  • Skin tightness or restricted movement in affected areas.
  • Pain or tenderness in the affected region.
  • In severe cases, muscle or bone involvement may occur, leading to deformities.

Diagnosis

Diagnosis is based on clinical examination and patient history. A dermatologist may perform a skin biopsy to confirm excessive collagen deposition. Imaging studies, such as X-rays or MRI, may be used to assess underlying tissue damage. Blood tests may rule out systemic scleroderma or other autoimmune conditions.

Treatment Options

  • Topical therapies: Corticosteroid creams or calcineurin inhibitors to reduce inflammation and skin thickening.
  • Systemic medications: Oral or injectable immunosuppressants for severe cases.
  • Physical therapy: To maintain mobility and manage contractures.
  • Surgical intervention: Rarely, for severe deformities or functional impairment.

Prognosis and Follow-Up

Prognosis varies depending on the extent and location of involvement. Early treatment can improve outcomes, but some cases may progress or cause permanent changes. Regular follow-up with a dermatologist or rheumatologist is recommended to monitor for complications and adjust treatment as needed.

Complications

  • Joint contractures or limited mobility.
  • Facial asymmetry or disfigurement.
  • Underlying tissue damage, such as muscle or bone involvement.
  • Psychological impact due to visible skin changes.

Lifestyle & Prevention

  • Protect skin from injury and excessive sun exposure.
  • Maintain a healthy lifestyle to support overall immune function.
  • Use moisturizers to keep skin supple and reduce tightness.
  • Avoid smoking, which may worsen tissue damage.

When to Seek Professional Help

Seek medical attention if you notice new or worsening skin thickening, pain, or functional limitations. Prompt evaluation is important to prevent long-term complications.

Tips for Medical Coders

When coding for linear scleroderma (L94.1), ensure documentation supports the diagnosis, including clinical findings and any associated complications. Verify that the condition is localized and not systemic scleroderma, as coding differs. Document the affected body region and any treatment provided to support accurate code assignment.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

L94.1 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.